| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2019 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 500 | $19.92 | $9,958.75 | -0.7% | |
| Sep 25, 2019 | CPIX Cumberland Pharmaceuticals Inc | Bernard Gordon R | Director | Sell | 11,570 | $5.29 | $61,260.70 | -44.7% | |
| Sep 20, 2019 | LNTH Lantheus Holdings, Inc. | Heino Mary Anne50 | President &CEO | Sell | 15,590 | $25.81 | $402,448.06 | -2.6% | |
| Sep 20, 2019 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 210,000 | $116.37 | $24,437,726.00 | - | |
| Sep 20, 2019 | LLY Eli Lilly & Co | Zulueta Alfonso G | SVP &President, Lilly Int'l | Sell | 4,500 | $117.00 | $526,500.00 | -11.7% | |
| Sep 19, 2019 | ALKS Alkermes Plc. | Pops Richard F57 | Director And CEO, Alkermes Plc | Sell | 100,000 | $21.54 | $2,153,550.00 | -12.2% | |
| Sep 19, 2019 | CPIX Cumberland Pharmaceuticals Inc | Bernard Gordon R | Director | Sell | 10,915 | $5.09 | $55,549.53 | -11.1% | |
| Sep 19, 2019 | CPIX Cumberland Pharmaceuticals Inc | Galante Joseph C47 | Director | Buy | 2,280 | $5.47 | $12,461.40 | +0.5% | |
| Sep 19, 2019 | CPIX Cumberland Pharmaceuticals Inc | Kazimi A J59 | Chairman And CEO | Buy | 2,280 | $5.47 | $12,461.40 | - | |
| Sep 19, 2019 | CPIX Cumberland Pharmaceuticals Inc | Krogulski Kenneth55 | Director | Buy | 2,470 | $5.47 | $13,499.85 | - | |
| Sep 18, 2019 | TEVA Teva Pharmaceutical Industries Ltd | Daniell Richard | Exec. VP, European Commercial | Sell | 1,176 | $7.82 | $9,196.67 | -41.2% | |
| Sep 18, 2019 | AMPH Amphastar Pharmaceuticals, Inc. | Shandell Jason B. | President And General Counsel | Sell | 7,340 | $21.32 | $156,509.35 | -4.8% | |
| Sep 18, 2019 | TEVA Teva Pharmaceutical Industries Ltd | McClellan Michael James | EVP, Chief Financial Officer | Sell | 1,406 | $7.83 | $11,010.81 | -8.3% | |
| Sep 18, 2019 | TEVA Teva Pharmaceutical Industries Ltd | Griffin Deborah A | Chief Accounting Officer | Sell | 2,376 | $7.83 | $18,607.17 | -100% | |
| Sep 18, 2019 | TEVA Teva Pharmaceutical Industries Ltd | Nazzi Gianfranco | EVP, Growth Markets Commercial | Sell | 962 | $7.82 | $7,523.13 | -8.3% | |
| Sep 18, 2019 | TEVA Teva Pharmaceutical Industries Ltd | O'Grady Brendan P. | EVP, North America Commercial | Sell | 494 | $7.83 | $3,868.66 | -18.8% | |
| Sep 18, 2019 | BUDZ Weed, Inc. | Breen Nicole M | Secretary And Treasurer | Sell | 29,604 | $0.45 | $13,452.92 | - | |
| Sep 17, 2019 | EGRX Eagle Pharmaceuticals, Inc. | Hudson Executive Capital LP49 | Director | Sell | 100 | $60.00 | $6,000.00 | - | |
| Sep 16, 2019 | AMPH Amphastar Pharmaceuticals, Inc. | Peters William J52 | CFO, SVP &Treasurer | Sell | 9,800 | $21.76 | $213,255.84 | -10.6% | |
| Sep 16, 2019 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 500 | $21.75 | $10,876.70 | -0.7% | |
| Sep 16, 2019 | ZTS Zoetis Inc. | Lewis Clinton A. Jr.46 | Executive Vice President | Sell | 6,123 | $120.05 | $735,066.15 | -14.7% | |
| Sep 13, 2019 | BHC Bausch Health Companies Inc. | Papa Joseph C | Chairman &CEO | Buy | 30,000 | $23.31 | $699,300.00 | +3.7% | |
| Sep 13, 2019 | ORGO Organogenesis Holdings Inc. | Katz Michael W | 10% Owner | Buy | 3,603 | $6.00 | $21,618.00 | +36.0% | |
| Sep 13, 2019 | AMPH Amphastar Pharmaceuticals, Inc. | Liawatidewi Yakob47 | SVP Corp Admin Center | Sell | 3,000 | $21.45 | $64,340.10 | -8.2% | |
| Sep 13, 2019 | ORGO Organogenesis Holdings Inc. | MacKie Wayne D | Director | Buy | 4,990 | $6.13 | $30,569.66 | +2.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.